Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124952972 | 12495297 | 2 | F | 20151029 | 20160704 | 20160624 | 20160708 | PER | US-PFIZER INC-2016306555 | PFIZER | 33.00 | YR | F | Y | 0.00000 | 20160708 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124952972 | 12495297 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | UNK (FLAG-IDA) | U | 71868 | ||||||||||
| 124952972 | 12495297 | 2 | SS | CYTARABINE. | CYTARABINE | 1 | SALVAGE 2 TREATMENT | U | 71868 | ||||||||||
| 124952972 | 12495297 | 3 | SS | CYTARABINE. | CYTARABINE | 1 | U | 71868 | |||||||||||
| 124952972 | 12495297 | 4 | SS | IDARUBICIN HCL | IDARUBICIN HYDROCHLORIDE | 1 | UNK (FLAG-IDA) | U | 50661 | ||||||||||
| 124952972 | 12495297 | 5 | SS | FLUDARABINE PHOSPHATE. | FLUDARABINE PHOSPHATE | 1 | UNK (FLAG-IDA) | U | 77790 | ||||||||||
| 124952972 | 12495297 | 6 | SS | G-CSF | GRANULOCYTE COLONY-STIMULATING FACTOR NOS | 1 | UNK (FLAG-IDA) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124952972 | 12495297 | 1 | Acute lymphocytic leukaemia |
| 124952972 | 12495297 | 2 | Salvage therapy |
| 124952972 | 12495297 | 3 | B-cell type acute leukaemia |
| 124952972 | 12495297 | 4 | B-cell type acute leukaemia |
| 124952972 | 12495297 | 5 | B-cell type acute leukaemia |
| 124952972 | 12495297 | 6 | B-cell type acute leukaemia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124952972 | 12495297 | B-cell type acute leukaemia | |
| 124952972 | 12495297 | Disease progression | |
| 124952972 | 12495297 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124952972 | 12495297 | 1 | 20150930 | 0 | ||
| 124952972 | 12495297 | 2 | 20151020 | 0 | ||
| 124952972 | 12495297 | 4 | 20150930 | 0 | ||
| 124952972 | 12495297 | 5 | 20150930 | 0 | ||
| 124952972 | 12495297 | 6 | 20150930 | 0 |